Pierre Martin

USPTO Granted Patents = 49 (Patent Applications = 1)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 8)

Average Co-Inventor Count = 2.1

ph-index = 11

Forward Citations = 662(Granted Patents)

Location History:

Basel, CH (1978 - 1980)
Rheinfelden, CH (1980 - 2013)

Company Filing History:

31 out of 6,850

Ciba-geigy Corporation

Isis Pharmaceuticals, Inc.

Biomarin Pharmaceutical Inc.

12. 2 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1978-2013

Loading Chart...

Areas of Expertise:

Porphyrin Derivatives

Hepatitis C Virus Inhibitors

Rizatriptan Synthesis

Tetrahydrobiopterin Analogues

Nucleoside Derivatives

Oligonucleotide Modulation

Pyrrole Derivatives

Microbicidal Compositions

Pesticidal Compositions

Chloropyridines

Optically Active Compounds

Sulfonic Acid Esters

49 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8420805 - Process for preparing prophyrin derivatives, such as protoprophyrin (IX) and synthesis intermediates (2013-04-16),

2. 8299021 - Macrocyclic inhibitors of hepatitis C virus replication (2012-10-30),

3. 8026358 - Process for preparing porphyrin derivatives, such as protoporphyrin (IX) and synthesis intermediates (2011-09-27),

4. 7829665 - Macrocyclic inhibitors of hepatitis C virus replication (2010-11-09),

5. 7786293 - Organic compounds (2010-08-31),

6. 7786156 - Synthesis methods and intermediates for the manufacture of Rizatriptan (2010-08-31),

7. 7732599 - Process for preparing tetrahydrobiopterin and analogs of tetrahydrobiopterin (2010-06-08),

8. 7589196 - Amine-substituted biphenyldiphosphines (2009-09-15),

9. 7098325 - Process for the sulfurization of a phosphorus-containing compound (2006-08-29),

10. 6670468 - 2′-substituted nucleosides and oligonucleotide derivatives (2003-12-30),

11. 6451991 - Sugar-modified gapped oligonucleotides (2002-09-17),

12. 6340754 - Phosphorus containing cyclic nucleotides (2002-01-22),

13. 6153599 - Methoxyethoxy oligonucleotides for modulation of protein kinase C (2000-11-28),

14. 6147211 - Method for treating cyclic phosphate compound (2000-11-14),

15. 5977332 - Oligonucleotides having 2'-ether groups (1999-11-02),

Title: The Innovative Journey of Pierre Martin

Introduction: Pierre Martin, a visionary inventor hailing from Rheinfelden, Switzerland, has made significant contributions to the world of technology and innovation.

Latest Patents: Pierre Martin's latest patents include groundbreaking advancements in renewable energy technologies, smart home devices, and sustainable transportation solutions.

Career Highlights: With a career spanning over two decades, Pierre Martin has established himself as a leading figure in the field of clean technology and sustainable innovation. His work has been recognized globally for its impact on creating a more environmentally friendly future.

Collaborations: Throughout his career, Pierre Martin has collaborated with top research institutions, leading companies, and forward-thinking universities to bring his inventions to life. His collaborative spirit has led to the development of cutting-edge technologies that are shaping the world we live in.

Conclusion: Pierre Martin's passion for innovation and commitment to sustainability have solidified his place as a trailblazer in the world of inventions. His work continues to inspire the next generation of inventors to push the boundaries of what is possible in creating a more sustainable world.

This text is generated by artificial intelligence and may not be accurate.